Blood Cancers Completed Phase 2 Trials for Ciclosporin (DB00091)

Also known as: Blood Cancer

IndicationStatusPhase
DBCOND0048268 (Blood Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00185640Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic MalignanciesTreatment
NCT00185692Allogeneic Transplantation From Related Haploidentical DonorsTreatment